{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:08:06Z","timestamp":1747454886545,"version":"3.40.5"},"reference-count":40,"publisher":"Sociedade Brasileira de Cardiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,29]]},"DOI":"10.36660\/abc.20210422","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T18:16:04Z","timestamp":1661883364000},"source":"Crossref","is-referenced-by-count":0,"title":["Associa\u00e7\u00e3o do Gen\u00f3tipo e Fen\u00f3tipo da Paraoxonase-1 com Angiografia Positiva para Doen\u00e7a Arterial Coronariana"],"prefix":"10.36660","author":[{"given":"Sara Saffar","family":"Soflaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Baktashian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiana Hosseinpour","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Saberi-Karimian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negin","family":"Kosari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Mouhebati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashallah","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibollah","family":"Esmaily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homa","family":"Falsoleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolfazl","family":"Nosrati-Tirkani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Sadabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon A.","family":"Ferns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoor","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Pasdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-6754","authenticated-orcid":false,"given":"Majid","family":"Ghayour-Mobarhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"2","key":"key20220830140353_B1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/icvts\/ivw117","article-title":"Acute Kidney Injury and Outcome Following Aortic Valve Replacement for Aortic Stenosis","volume":"23","author":"Helgason","year":"2016","unstructured":"1. Helgason D, Helgadottir S, Viktorsson SA, Orrason AW, Ingvarsdottir IL, Geirsson A, et al. Acute Kidney Injury and Outcome Following Aortic Valve Replacement for Aortic Stenosis. Interact Cardiovasc Thorac Surg. 2016;23(2):266-72. doi: 10.1093\/icvts\/ivw117.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"4","key":"key20220830140353_B2","first-page":"204","article-title":"Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention","volume":"22","author":"Sarrafzadegan","year":"2019","unstructured":"2. Sarrafzadegan N, Mohammmadifard N. Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention. Arch Iran Med. 2019;22(4):204-10.","journal-title":"Arch Iran Med"},{"issue":"201","key":"key20220830140353_B3","first-page":"1225","article-title":"Periodic Health Assessment in Office Workers of Isfahan Insurance Organization, Iran","volume":"30","author":"Baktashian","year":"2012","unstructured":"3. Baktashian M, Riaziat MD AR, Moshaveri F, Rouzbahani R. Periodic Health Assessment in Office Workers of Isfahan Insurance Organization, Iran. Journal of Isfahan Medical School. 2012;30(201):1225-33.","journal-title":"Journal of Isfahan Medical School"},{"key":"key20220830140353_B4","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-9-167","article-title":"Third National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: Methods and Results on Prevalence of Diabetes, Hypertension, Obesity, Central Obesity, and Dyslipidemia","volume":"9","author":"Esteghamati","year":"2009","unstructured":"4. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: Methods and Results on Prevalence of Diabetes, Hypertension, Obesity, Central Obesity, and Dyslipidemia. BMC Public Health. 2009;9:167. doi: 10.1186\/1471-2458-9-167.","journal-title":"BMC Public Health"},{"issue":"6","key":"key20220830140353_B5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clinbiochem.2007.12.008","article-title":"Prooxidant-antioxidant Balance as a New Risk Factor in Patients with Angiographically Defined Coronary Artery Disease","volume":"41","author":"Alamdari","year":"2008","unstructured":"5. Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, Parizadeh MR, Moohebati M, Ghafoori F, et al. Prooxidant-antioxidant Balance as a New Risk Factor in Patients with Angiographically Defined Coronary Artery Disease. Clin Biochem. 2008;41(6):375-80. doi: 10.1016\/j.clinbiochem.2007.12.008.","journal-title":"Clin Biochem"},{"issue":"3","key":"key20220830140353_B6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0531-5565(99)00005-4","article-title":"The Aging Paradox: Free Radical Theory of Aging","volume":"34","author":"Ashok","year":"1999","unstructured":"6. Ashok BT, Ali R. The Aging Paradox: Free Radical Theory of Aging. Exp Gerontol. 1999;34(3):293-303. doi: 10.1016\/s0531-5565(99)00005-4.","journal-title":"Exp Gerontol"},{"key":"key20220830140353_B7","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/231502","article-title":"Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-syndrome-related Risk of Coronary Artery Disease","volume":"2012","author":"Martinelli","year":"2012","unstructured":"7. Martinelli N, Micaglio R, Consoli L, Guarini P, Grison E, Pizzolo F, et al. Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-syndrome-related Risk of Coronary Artery Disease. Exp Diabetes Res. 2012;2012:231502. doi: 10.1155\/2012\/231502.","journal-title":"Exp Diabetes Res"},{"issue":"4","key":"key20220830140353_B8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bcp.2004.08.027","article-title":"Modulation of Paraoxonase (PON1) Activity","volume":"69","author":"Costa","year":"2005","unstructured":"8. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of Paraoxonase (PON1) Activity. Biochem Pharmacol. 2005;69(4):541-50. doi: 10.1016\/j.bcp.2004.08.027.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"key20220830140353_B9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0021-9150(99)00340-8","article-title":"Evidence for Association Between Paraoxonase Gene Polymorphisms and Atherosclerotic Diseases","volume":"149","author":"Imai","year":"2000","unstructured":"9. Imai Y, Morita H, Kurihara H, Sugiyama T, Kato N, Ebihara A, et al. Evidence for Association Between Paraoxonase Gene Polymorphisms and Atherosclerotic Diseases. Atherosclerosis. 2000;149(2):435-42. doi: 10.1016\/s0021-9150(99)00340-8.","journal-title":"Atherosclerosis"},{"issue":"6","key":"key20220830140353_B10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/ars.2010.3774","article-title":"The Human Paraoxonase Gene Cluster as a Target in the Treatment of Atherosclerosis","volume":"16","author":"She","year":"2012","unstructured":"10. She ZG, Chen HZ, Yan Y, Li H, Liu DP. The Human Paraoxonase Gene Cluster as a Target in the Treatment of Atherosclerosis. Antioxid Redox Signal. 2012;16(6):597-632. doi: 10.1089\/ars.2010.3774.","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"key20220830140353_B11","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1194\/jlr.P030601","article-title":"Dietary Cholesterol Increases Paraoxonase 1 Enzyme Activity","volume":"53","author":"Kim","year":"2012","unstructured":"11. Kim DS, Burt AA, Ranchalis JE, Richter RJ, Marshall JK, Nakayama KS, et al. Dietary Cholesterol Increases Paraoxonase 1 Enzyme Activity. J Lipid Res. 2012;53(11):2450-8. doi: 10.1194\/jlr.P030601.","journal-title":"J Lipid Res"},{"issue":"7","key":"key20220830140353_B12","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1194\/jlr.P004960","article-title":"Paraoxonase 1 R\/Q Alleles are Associated with Differential Accumulation of Saturated Versus 20:5n3 Fatty Acid in Human Adipose Tissue","volume":"51","author":"Zafiropoulos","year":"2010","unstructured":"12. Zafiropoulos A, Linardakis M, Jansen EH, Tsatsakis AM, Kafatos A, Tzanakakis GN. Paraoxonase 1 R\/Q Alleles are Associated with Differential Accumulation of Saturated Versus 20:5n3 Fatty Acid in Human Adipose Tissue. J Lipid Res. 2010;51(7):1991-2000. doi: 10.1194\/jlr.P004960.","journal-title":"J Lipid Res"},{"issue":"1-3","key":"key20220830140353_B13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cbi.2010.03.033","article-title":"Human PON1, a Biomarker of Risk of Disease and Exposure","volume":"187","author":"Furlong","year":"2010","unstructured":"13. Furlong CE, Suzuki SM, Stevens RC, Marsillach J, Richter RJ, Jarvik GP, et al. Human PON1, a Biomarker of Risk of Disease and Exposure. Chem Biol Interact. 2010;187(1-3):355-61. doi: 10.1016\/j.cbi.2010.03.033.","journal-title":"Chem Biol Interact"},{"issue":"9","key":"key20220830140353_B14","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s001250100610","article-title":"The paraoxonase PON1 promoter polymorphism C (-107) T is associated with increased serum glucose concentrations in non-diabetic patients","volume":"44","author":"Leviev","year":"2001","unstructured":"14. Leviev I, Kalix B, Meynet M-CB, James R. The paraoxonase PON1 promoter polymorphism C (-107) T is associated with increased serum glucose concentrations in non-diabetic patients. Diabetologia. 2001;44(9):1177-83.","journal-title":"Diabetologia"},{"issue":"2","key":"key20220830140353_B15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0021-9150(01)00668-2","article-title":"High Expressor Paraoxonase PON1 Gene Promoter Polymorphisms are Associated with Reduced Risk of Vascular Disease in Younger Coronary Patients","volume":"161","author":"Leviev","year":"2002","unstructured":"15. Leviev I, Poirier O, Nicaud V, Evans A, Kee F, Arveiler D, et al. High Expressor Paraoxonase PON1 Gene Promoter Polymorphisms are Associated with Reduced Risk of Vascular Disease in Younger Coronary Patients. Atherosclerosis. 2002;161(2):463-7. doi: 10.1016\/s0021-9150(01)00668-2.","journal-title":"Atherosclerosis"},{"issue":"3","key":"key20220830140353_B16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archneur.61.3.351","article-title":"The Combined Effect of Paraoxonase Promoter and Coding Region Polymorphisms on the Risk of Arterial Ischemic Stroke Among Young Adults","volume":"61","author":"Voetsch","year":"2004","unstructured":"16. Voetsch B, Benke KS, Panhuysen CI, Damasceno BP, Loscalzo J. The Combined Effect of Paraoxonase Promoter and Coding Region Polymorphisms on the Risk of Arterial Ischemic Stroke Among Young Adults. Arch Neurol. 2004;61(3):351-6. doi: 10.1001\/archneur.61.3.351.","journal-title":"Arch Neurol"},{"issue":"8","key":"key20220830140353_B17","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2337\/diabetes.49.8.1390","article-title":"Promoter Polymorphism T(-107)C of the Paraoxonase PON1 Gene is a Risk Factor for Coronary Heart Disease in Type 2 Diabetic Patients","volume":"49","author":"James","year":"2000","unstructured":"17. James RW, Leviev I, Ruiz J, Passa P, Froguel P, Garin MC. Promoter Polymorphism T(-107)C of the Paraoxonase PON1 Gene is a Risk Factor for Coronary Heart Disease in Type 2 Diabetic Patients. Diabetes. 2000;49(8):1390-3. doi: 10.2337\/diabetes.49.8.1390.","journal-title":"Diabetes"},{"issue":"9","key":"key20220830140353_B18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ejcn.2014.105","article-title":"Association between PON1 rs662 Polymorphism and Coronary Artery Disease","volume":"68","author":"Liu","year":"2014","unstructured":"18. Liu T, Zhang X, Zhang J, Liang Z, Cai W, Huang M, et al. Association between PON1 rs662 Polymorphism and Coronary Artery Disease. Eur J Clin Nutr. 2014;68(9):1029-35. doi: 10.1038\/ejcn.2014.105.","journal-title":"Eur J Clin Nutr"},{"issue":"8","key":"key20220830140353_B19","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1007\/s11033-011-0696-3","article-title":"Paraoxonase Arg 192 Allele is an Independent Risk Factor for Three-vessel Stenosis of Coronary Artery Disease","volume":"38","author":"Vaisi-Raygani","year":"2011","unstructured":"19. Vaisi-Raygani A, Ghaneialvar H, Rahimi Z, Tavilani H, Pourmotabbed T, Shakiba E, et al. Paraoxonase Arg 192 Allele is an Independent Risk Factor for Three-vessel Stenosis of Coronary Artery Disease. Mol Biol Rep. 2011;38(8):5421-8. doi: 10.1007\/s11033-011-0696-3.","journal-title":"Mol Biol Rep"},{"issue":"7","key":"key20220830140353_B20","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1007\/s11033-020-05585-2","article-title":"Genetic Associations and Serum Paraoxonase Levels with Atherosclerosis in Western Iranian Patients","volume":"47","author":"Shahsavari","year":"2020","unstructured":"20. Shahsavari G, Nouryazdan N, Adibhesami G, Birjandi M. Genetic Associations and Serum Paraoxonase Levels with Atherosclerosis in Western Iranian Patients. Mol Biol Rep. 2020;47(7):5137-44. doi: 10.1007\/s11033-020-05585-2.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"key20220830140353_B21","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.numecd.2020.12.026","article-title":"Improved Risk Assessment of Coronary Artery Disease by Substituting Paraoxonase 1 Activity for HDL-C: Novel Cardiometabolic Biomarkers Based on HDL Functionality","volume":"31","author":"Mahrooz","year":"2021","unstructured":"21. Mahrooz A, Shokri Y, Variji A, Zargari M, Alizadeh A, Mehtarian E. Improved Risk Assessment of Coronary Artery Disease by Substituting Paraoxonase 1 Activity for HDL-C: Novel Cardiometabolic Biomarkers Based on HDL Functionality. Nutr Metab Cardiovasc Dis. 2021;31(4):1166-76. doi: 10.1016\/j.numecd.2020.12.026.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"key20220830140353_B22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.arcmed.2019.02.002","article-title":"Genotypes of Common Polymorphisms in the PON1 Gene Associated with Paraoxonase Activity as Cardiovascular Risk Factor","volume":"49","author":"Moreno-God\u00ednez","year":"2018","unstructured":"22. Moreno-God\u00ednez ME, Galarce-Sosa C, Cahua-Pablo J\u00c1, Rojas-Garc\u00eda AE, Huerta-Beristain G, Alarc\u00f3n-Romero LDC, et al. Genotypes of Common Polymorphisms in the PON1 Gene Associated with Paraoxonase Activity as Cardiovascular Risk Factor. Arch Med Res. 2018;49(7):486-96. doi: 10.1016\/j.arcmed.2019.02.002.","journal-title":"Arch Med Res"},{"key":"key20220830140353_B23","doi-asserted-by":"crossref","first-page":"116646","DOI":"10.1016\/j.lfs.2019.116646","article-title":"A Meta-analysis on Relationship Between Paraoxonase 1 Polymorphisms and Atherosclerotic Cardiovascular Diseases","volume":"232","author":"Zeng","year":"2019","unstructured":"23. Zeng Q, Zeng J. A Meta-analysis on Relationship Between Paraoxonase 1 Polymorphisms and Atherosclerotic Cardiovascular Diseases. Life Sci. 2019;232:116646. doi: 10.1016\/j.lfs.2019.116646.","journal-title":"Life Sci"},{"issue":"9410","key":"key20220830140353_B24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(04)15642-0","article-title":"Four Paraoxonase Gene Polymorphisms in 11212 Cases of Coronary Heart Disease and 12786 Controls: Meta-analysis of 43 Studies","volume":"363","author":"Wheeler","year":"2004","unstructured":"24. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J. Four Paraoxonase Gene Polymorphisms in 11212 Cases of Coronary Heart Disease and 12786 Controls: Meta-analysis of 43 Studies. Lancet. 2004;363(9410):689-95. doi: 10.1016\/S0140-6736(04)15642-0.","journal-title":"Lancet"},{"issue":"2","key":"key20220830140353_B25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2010.11.028","article-title":"Four Genetic Polymorphisms of Paraoxonase Gene and Risk of Coronary Heart Disease: A Meta-analysis Based on 88 Case-control Studies","volume":"214","author":"Wang","year":"2011","unstructured":"25. Wang M, Lang X, Zou L, Huang S, Xu Z. Four Genetic Polymorphisms of Paraoxonase Gene and Risk of Coronary Heart Disease: A Meta-analysis Based on 88 Case-control Studies. Atherosclerosis. 2011;214(2):377-85. doi: 10.1016\/j.atherosclerosis.2010.11.028.","journal-title":"Atherosclerosis"},{"issue":"3","key":"key20220830140353_B26","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s11033-011-1027-4","article-title":"Synergism Between Paraoxonase Arg 192 and the Angiotensin Converting Enzyme D Allele is Associated with Severity of Coronary Artery Disease","volume":"39","author":"Vaisi-Raygani","year":"2012","unstructured":"26. Vaisi-Raygani A, Rahimi Z, Tavilani H, Vaisi-Raygani H, Kiani A, Aminian M, et al. Synergism Between Paraoxonase Arg 192 and the Angiotensin Converting Enzyme D Allele is Associated with Severity of Coronary Artery Disease. Mol Biol Rep. 2012;39(3):2723-31. doi: 10.1007\/s11033-011-1027-4.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"key20220830140353_B27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.gene.2012.06.031","article-title":"Two- and three-locus Haplotypes of the Paraoxonase (PON1) Gene are Associated with Coronary Artery Disease in Asian Indians","volume":"506","author":"Ahmad","year":"2012","unstructured":"27. Ahmad I, Narang R, Venkatraman A, Das N. Two- and three-locus Haplotypes of the Paraoxonase (PON1) Gene are Associated with Coronary Artery Disease in Asian Indians. Gene. 2012;506(1):242-7. doi: 10.1016\/j.gene.2012.06.031.","journal-title":"Gene"},{"issue":"3","key":"key20220830140353_B28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.thromres.2008.03.004","article-title":"Paraoxonase 1 Gene Promoter Polymorphisms are Associated with the Extent of Stenosis in Coronary Arteries","volume":"123","author":"Najafi","year":"2009","unstructured":"28. Najafi M, Gohari LH, Firoozrai M. Paraoxonase 1 Gene Promoter Polymorphisms are Associated with the Extent of Stenosis in Coronary Arteries. Thromb Res. 2009;123(3):503-10. doi: 10.1016\/j.thromres.2008.03.004.","journal-title":"Thromb Res"},{"issue":"11","key":"key20220830140353_B29","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/ATVBAHA.112.253930","article-title":"Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities with Cardiovascular Risk","volume":"32","author":"Tang","year":"2012","unstructured":"29. Tang WH, Hartiala J, Fan Y, Wu Y, Stewart AF, Erdmann J, et al. Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities with Cardiovascular Risk. Arterioscler Thromb Vasc Biol. 2012;32(11):2803-12. doi: 10.1161\/ATVBAHA.112.253930.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"key20220830140353_B30","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity with Systemic Oxidative Stress and Cardiovascular Risk","volume":"299","author":"Bhattacharyya","year":"2008","unstructured":"30. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, et al. Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity with Systemic Oxidative Stress and Cardiovascular Risk. JAMA. 2008;299(11):1265-76. doi: 10.1001\/jama.299.11.1265.","journal-title":"JAMA"},{"key":"key20220830140353_B31","doi-asserted-by":"crossref","first-page":"103519","DOI":"10.1016\/j.etap.2020.103519","article-title":"Effect of Gene-environment Interaction (arsenic exposure - PON1 Q192R polymorphism) on Cardiovascular Disease Biomarkers in Mexican Population","volume":"81","author":"Ochoa-Mart\u00ednez","year":"2021","unstructured":"31. Ochoa-Mart\u00ednez \u00c1C, Araiza-Gamboa Y, Varela-Silva JA, Orta-Garc\u00eda ST, Carrizales-Y\u00e1\u00f1ez L, P\u00e9rez-Maldonado IN. Effect of Gene-environment Interaction (arsenic exposure - PON1 Q192R polymorphism) on Cardiovascular Disease Biomarkers in Mexican Population. Environ Toxicol Pharmacol. 2021;81:103519. doi: 10.1016\/j.etap.2020.103519.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"10","key":"key20220830140353_B32","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.18.10.1617","article-title":"Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves its Free Sulfhydryl Group and is Different from that Required for its Arylesterase\/paraoxonase Activities: Selective Action of Human Paraoxonase Allozymes Q and R","volume":"18","author":"Aviram","year":"1998","unstructured":"32. Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, et al. Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves its Free Sulfhydryl Group and is Different from that Required for its Arylesterase\/paraoxonase Activities: Selective Action of Human Paraoxonase Allozymes Q and R. Arterioscler Thromb Vasc Biol. 1998;18(10):1617-24. doi: 10.1161\/01.atv.18.10.1617.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"key20220830140353_B33","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/320600","article-title":"Effects of 5\u2019 Regulatory-region Polymorphisms on Paraoxonase-gene (PON1) Expression","volume":"68","author":"Brophy","year":"2001","unstructured":"33. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. Effects of 5\u2019 Regulatory-region Polymorphisms on Paraoxonase-gene (PON1) Expression. Am J Hum Genet. 2001;68(6):1428-36. doi: 10.1086\/320600.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"key20220830140353_B34","doi-asserted-by":"crossref","first-page":"e17805","DOI":"10.1371\/journal.pone.0017805","article-title":"Paraoxonase 1 (PON1) Polymorphisms, Haplotypes and Activity in Predicting Cad Risk in North-West Indian Punjabis","volume":"6","author":"Gupta","year":"2011","unstructured":"34. Gupta N, Singh S, Maturu VN, Sharma YP, Gill KD. Paraoxonase 1 (PON1) Polymorphisms, Haplotypes and Activity in Predicting Cad Risk in North-West Indian Punjabis. PLoS One. 2011;6(5):e17805. doi: 10.1371\/journal.pone.0017805.","journal-title":"PLoS One"},{"issue":"9","key":"key20220830140353_B35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.freeradbiomed.2004.07.034","article-title":"Paraoxonase 1 and Atherosclerosis: Is the Gene or the Protein More Important?","volume":"37","author":"Mackness","year":"2004","unstructured":"35. Mackness M, Mackness B. Paraoxonase 1 and Atherosclerosis: Is the Gene or the Protein More Important? Free Radic Biol Med. 2004;37(9):1317-23. doi: 10.1016\/j.freeradbiomed.2004.07.034.","journal-title":"Free Radic Biol Med"},{"key":"key20220830140353_B36","volume-title":"Human Serum Paraoxonase\/arylesterase","author":"La Du","year":"1992","unstructured":"36. La Du B. Human Serum Paraoxonase\/arylesterase. Amsterdam: Elsevier; 1992."},{"issue":"3","key":"key20220830140353_B37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clnu.2003.10.002","article-title":"Pomegranate Juice Consumption for 3 Years by Patients with Carotid Artery Stenosis Reduces Common Carotid Intima-media Thickness, Blood Pressure and LDL Oxidation","volume":"23","author":"Aviram","year":"2004","unstructured":"37. Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, et al. Pomegranate Juice Consumption for 3 Years by Patients with Carotid Artery Stenosis Reduces Common Carotid Intima-media Thickness, Blood Pressure and LDL Oxidation. Clin Nutr. 2004;23(3):423-33. doi: 10.1016\/j.clnu.2003.10.002.","journal-title":"Clin Nutr"},{"issue":"4","key":"key20220830140353_B38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1194\/jlr.M200432-JLR200","article-title":"Serum Paraoxonase: Effect of the Apolipoprotein Composition of HDL and the Acute Phase Response","volume":"44","author":"Cabana","year":"2003","unstructured":"38. Cabana VG, Reardon CA, Feng N, Neath S, Lukens J, Getz GS. Serum Paraoxonase: Effect of the Apolipoprotein Composition of HDL and the Acute Phase Response. J Lipid Res. 2003;44(4):780-92. doi: 10.1194\/jlr.M200432-JLR200.","journal-title":"J Lipid Res"},{"key":"key20220830140353_B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2019.07.010","article-title":"The Epigenetic Regulation of Paraoxonase 1 (PON1) as an Important Enzyme in HDL Function: The Missing Link Between Environmental and Genetic Regulation","volume":"73","author":"Mahrooz","year":"2019","unstructured":"39. Mahrooz A, Mackness M, Bagheri A, Ghaffari-Cherati M, Masoumi P. The Epigenetic Regulation of Paraoxonase 1 (PON1) as an Important Enzyme in HDL Function: The Missing Link Between Environmental and Genetic Regulation. Clin Biochem. 2019;73:1-10. doi: 10.1016\/j.clinbiochem.2019.07.010.","journal-title":"Clin Biochem"},{"issue":"11","key":"key20220830140353_B40","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1194\/jlr.M600297-JLR200","article-title":"The 192R\/Q Polymorphs of Serum Paraoxonase PON1 Differ in HDL Binding, Lipolactonase Stimulation, and Cholesterol Efflux","volume":"47","author":"Gaidukov","year":"2006","unstructured":"40. Gaidukov L, Rosenblat M, Aviram M, Tawfik DS. The 192R\/Q Polymorphs of Serum Paraoxonase PON1 Differ in HDL Binding, Lipolactonase Stimulation, and Cholesterol Efflux. J Lipid Res. 2006;47(11):2492-502. doi: 10.1194\/jlr.M600297-JLR200.","journal-title":"J Lipid Res"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/associacao-do-genotipo-e-fenotipo-da-paraoxonase-1-com-angiografia-positiva-para-doenca-arterial-coronariana\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:10:26Z","timestamp":1747401026000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/associacao-do-genotipo-e-fenotipo-da-paraoxonase-1-com-angiografia-positiva-para-doenca-arterial-coronariana\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":40,"alternative-id":["10.36660\/abc.20210422"],"URL":"https:\/\/doi.org\/10.36660\/abc.20210422","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2022,8,29]]}}}